AI adoption is accelerating rapidly, yet patient advocacy organizational capacity and public trust remain uneven. This moment represents an important transition for patient advocacy, as rapid technological change intersects with evolving public expectations and concerns.
ASCO is a marathon that demands preparation. We all understand this. The question is how best to prepare. With this question in mind, before the abstracts drop and the meetings…
Over the past several years, prominent entry points into care for patients seeking treatment for chronic conditions, particularly obesity and its related comorbidities, are compounding pharmacies and telehealth platforms. For…
Every year, patient advocacy teams across pharma and biotech dedicate enormous energy to supporting organizations across the disease landscape. Lately, many teams have been asking a powerful question: How do…
The idea that the cost of engaging patients in the development process is too much – too much time, too much money, too much work – is the worst sort…
Topline findings from a survey of more than 600 caregivers now available for download.
Learn More